COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR ASSOCIATED STROMA OR TUMOR CELLS AND OTHER PATHWAYS Read more about COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR ASSOCIATED STROMA OR TUMOR CELLS AND OTHER PATHWAYS US Application 62/009,371Filed on 2014-06-09
COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND TUMOR VASCULATURE Read more about COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND TUMOR VASCULATURE US Application 62/009,369Filed on 2014-06-09
Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses Read more about Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses US Application 62/026,221Filed on 2014-07-18
Compounds that Bind to Human Immunodeficiency Virus Rev Response Element Read more about Compounds that Bind to Human Immunodeficiency Virus Rev Response Element US Application 61/934,379Filed on 2014-01-31
Methods For Producing Autologous T Cells Useful To Treat B Cell Malignancies And Other Cancers Read more about Methods For Producing Autologous T Cells Useful To Treat B Cell Malignancies And Other Cancers US Application 61/935,833Filed on 2014-02-04
HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR 5T4 AND METHODS OF THEIR USE Read more about HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR 5T4 AND METHODS OF THEIR USE US Application 62/034,995Filed on 2014-08-08
Combination Of Griffithsin With Other Substances To Make A Product For The Prevention Of STD Read more about Combination Of Griffithsin With Other Substances To Make A Product For The Prevention Of STD US Application 61/932,706Filed on 2014-01-28
PHOTO-CONTROLLED REMOVAL OF TARGETS IN VITRO AND IN VIVO Read more about PHOTO-CONTROLLED REMOVAL OF TARGETS IN VITRO AND IN VIVO US Application 62/034,990Filed on 2014-08-08
Triggering RNA Interference With RNA, RNA-DNA And DNA-RNA Nanoparticles Read more about Triggering RNA Interference With RNA, RNA-DNA And DNA-RNA Nanoparticles US Application 61/990,094Filed on 2014-05-07
Polyketal Nanoparticles Including A CPG Oligodeoxynucleotide For The Treatment of Lung Cancer Read more about Polyketal Nanoparticles Including A CPG Oligodeoxynucleotide For The Treatment of Lung Cancer US Application 62/024,657Filed on 2014-07-15